Emerson Sebastião1, Brian M Sandroff1, Yvonne C Learmonth1, Robert W Motl2. 1. Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL. 2. Department of Kinesiology and Community Health, University of Illinois at Urbana-Champaign, Urbana, IL. Electronic address: robmotl@illinois.edu.
Abstract
OBJECTIVE: To examine the validity of the timed Up and Go (TUG) test as a measure of functional mobility in persons with multiple sclerosis (MS) by using a comprehensive framework based on construct validity (ie, convergent and divergent validity). DESIGN: Cross-sectional study. SETTING: Hospital setting. PARTICIPANTS: Community-residing persons with MS (N=47). INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Main outcome measures included the TUG test, timed 25-foot walk test, 6-minute walk test, Multiple Sclerosis Walking Scale-12, Late-Life Function and Disability Instrument, posturography evaluation, Activities-specific Balance Confidence scale, Symbol Digits Modalities Test, Expanded Disability Status Scale, and the number of steps taken per day. RESULTS: The TUG test was strongly associated with other valid outcome measures of ambulatory mobility (Spearman rank correlation, rs=.71-.90) and disability status (rs=.80), moderately to strongly associated with balance confidence (rs=.66), and weakly associated with postural control (ie, balance) (rs=.31). The TUG test was moderately associated with cognitive processing speed (rs=.59), but not associated with other nonambulatory measures (ie, Late-Life Function and Disability Instrument-upper extremity function). CONCLUSIONS: Our findings support the validity of the TUG test as a measure of functional mobility. This warrants its inclusion in patients' assessment alongside other valid measures of functional mobility in both clinical and research practice in persons with MS.
OBJECTIVE: To examine the validity of the timed Up and Go (TUG) test as a measure of functional mobility in persons with multiple sclerosis (MS) by using a comprehensive framework based on construct validity (ie, convergent and divergent validity). DESIGN: Cross-sectional study. SETTING: Hospital setting. PARTICIPANTS: Community-residing persons with MS (N=47). INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Main outcome measures included the TUG test, timed 25-foot walk test, 6-minute walk test, Multiple Sclerosis Walking Scale-12, Late-Life Function and Disability Instrument, posturography evaluation, Activities-specific Balance Confidence scale, Symbol Digits Modalities Test, Expanded Disability Status Scale, and the number of steps taken per day. RESULTS: The TUG test was strongly associated with other valid outcome measures of ambulatory mobility (Spearman rank correlation, rs=.71-.90) and disability status (rs=.80), moderately to strongly associated with balance confidence (rs=.66), and weakly associated with postural control (ie, balance) (rs=.31). The TUG test was moderately associated with cognitive processing speed (rs=.59), but not associated with other nonambulatory measures (ie, Late-Life Function and Disability Instrument-upper extremity function). CONCLUSIONS: Our findings support the validity of the TUG test as a measure of functional mobility. This warrants its inclusion in patients' assessment alongside other valid measures of functional mobility in both clinical and research practice in persons with MS.
Authors: Douglas N Martini; Eline Zeeboer; Andrea Hildebrand; Brett W Fling; Cinda L Hugos; Michelle H Cameron Journal: Arch Phys Med Rehabil Date: 2018-06-26 Impact factor: 3.966
Authors: V J Block; A Lizée; E Crabtree-Hartman; C J Bevan; J S Graves; R Bove; A J Green; B Nourbakhsh; M Tremblay; P-A Gourraud; M Y Ng; M J Pletcher; J E Olgin; G M Marcus; D D Allen; B A C Cree; J M Gelfand Journal: J Neurol Date: 2016-11-28 Impact factor: 4.849
Authors: Marcia Aparecida Ciol; Patricia Noritake Matsuda; Seema Rani Khurana; Melissa Jaclyn Cline; Jacob Jonathan Sosnoff; George Howard Kraft Journal: Int J MS Care Date: 2017 Jul-Aug
Authors: Zongqi Xia; Sonya U Steele; Anshika Bakshi; Sarah R Clarkson; Charles C White; Matthew K Schindler; Govind Nair; Blake E Dewey; Lauren R Price; Joan Ohayon; Lori B Chibnik; Irene C M Cortese; Philip L De Jager; Daniel S Reich Journal: JAMA Neurol Date: 2017-03-01 Impact factor: 18.302
Authors: Lorena Lorefice; G Coghe; G Fenu; M Porta; G Pilloni; J Frau; F Corona; V Sechi; M A Barracciu; M G Marrosu; M Pau; E Cocco Journal: J Neurol Date: 2017-09-11 Impact factor: 4.849
Authors: Karine Wendrich; Pim van Oirschot; Marijn Bart Martens; Marco Heerings; Peter Joseph Jongen; Lotte Krabbenborg Journal: Int J MS Care Date: 2019 Nov-Dec